lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

Now published in The Lancet

Scoring Systems for Predicting Mortality for Severe Patients with COVID-19

23 Pages Posted: 27 May 2020

See all articles by Yufeng Shang

Yufeng Shang

Wuhan University - Department of Hematology

Tao Liu

Wuhan University - Department of Urology

Yongchang Wei

Wuhan University - Department of Radiation and Medical Oncology

Jingfeng Li

Wuhan University - Department of Orthopedics

Liang Shao

Wuhan University - Department of Hematology

Minghui Liu

Wuhan University - Department of Hematology

Yongxi Zhang

Wuhan University - Department of Infectious Disease

Zhigang Zhao

Wuhan University - Emergency Center

Haibo Xu

Wuhan University - Department of Radiology

Zhiyong Peng

Wuhan University - Department of Critical Care Medicine

Fuling Zhou

Wuhan University - Department of Hematology

Xinghuan Wang

Wuhan University - Center for Evidence-Based and Translational Medicine; Wuhan University - Department of Urology; Wuhan University - Medical Research Institute

More...

Abstract

Background: Coronavirus disease 2019 (COVID-19) has been widely spread and caused tens of thousands of deaths, mainly in patients with severe COVID-19.

Methods: Patients with COVID-19 were retrospectively analyzed. Clinical characteristics were compared, and LASSO regression as well as multivariate analysis were used to screen variables and establish prediction model.

Findings: A total of 2529 patients with COVID-19 was retrospectively analyzed, and 452 eligible severe COVID-19 were used for finally analysis. In training cohort, the median age was 66·0 years while it was 73·0 years in non-survivors. Patients aged 60-75 years accounted for the largest proportion of infected populations and mortality toll. Anti-SARS-CoV-2 antibodies were monitored up to 54 days, and IgG levels reached the highest during 20-30 days. About 60.2% of severe patients had complications. Acute myocardial injury was the earliest injured organ, whereas the time from acute kidney injury to death was the shortest. Age, diabetes, coronary heart disease (CHD), percentage of lymphocytes (LYM%), procalcitonin (PCT), serum urea, C reactive protein and D-dimer (DD), were identified associated with mortality by LASSO binary logistic regression. Then multivariate analysis was performed to conclude that old age, CHD, LYM%, PCT and DD remained independent risk factors for mortality. Based on the above variables, a scoring system of COVID-19 (CSS) was established and divided into low-risk and high-risk groups. This model displayed good discrimination (AUC=0·919) and calibration (P =0·264). The complications in low-risk and high-risk groups were significantly different. We also found that the use of corticosteroids in low-risk groups increased hospital stays by 4·5 days (P =0·036) and durations of disease by 7·5 days (P =0 · 012) compared with no corticosteroids.

Interpretation: Old age, CHD, LYM%, PCT and DD were independently related to mortality. CSS was useful for predicting in-hospital mortality and complications, and it could help clinicians to identify high-risk patients with poor prognosis.

Funding Statement: This work was supported by the Key Project for Anti-2019 novel Coronavirus Pneumonia from the Ministry of Science and Technology, China (grant number 2020YFC0845500).

Declaration of Interests: All authors declare no competing interests.

Ethics Approval Statement: This study was conducted according to the principles of Helsinki and approved by the Ethics Committee of Zhongnan Hospital of Wuhan University (No.2020063).

Keywords: COVID-19; critical ill; scoring system; antibody; mortality

Suggested Citation

Shang, Yufeng and Liu, Tao and Wei, Yongchang and Li, Jingfeng and Shao, Liang and Liu, Minghui and Zhang, Yongxi and Zhao, Zhigang and Xu, Haibo and Peng, Zhiyong and Zhou, Fuling and Wang, Xinghuan, Scoring Systems for Predicting Mortality for Severe Patients with COVID-19 (4/17/2020). , EClinicalMedicine, July 2020, https://doi.org/10.1016/j.eclinm.2020.100426, Available at SSRN: https://ssrn.com/abstract=3582752 or http://dx.doi.org/10.2139/ssrn.3582752

Yufeng Shang

Wuhan University - Department of Hematology

China

Tao Liu

Wuhan University - Department of Urology

China

Yongchang Wei

Wuhan University - Department of Radiation and Medical Oncology

Wuhan
China

Jingfeng Li

Wuhan University - Department of Orthopedics

Wuhan, 430071
China

Liang Shao

Wuhan University - Department of Hematology

China

Minghui Liu

Wuhan University - Department of Hematology

China

Yongxi Zhang

Wuhan University - Department of Infectious Disease ( email )

China

Zhigang Zhao

Wuhan University - Emergency Center

China

Haibo Xu

Wuhan University - Department of Radiology ( email )

China

Zhiyong Peng

Wuhan University - Department of Critical Care Medicine ( email )

Wuhan, 430071
China

Fuling Zhou (Contact Author)

Wuhan University - Department of Hematology ( email )

China

Xinghuan Wang

Wuhan University - Center for Evidence-Based and Translational Medicine ( email )

China

Wuhan University - Department of Urology ( email )

China

Wuhan University - Medical Research Institute ( email )

Wuhan
China

Click here to go to TheLancet.com

Paper statistics

Abstract Views
852
Downloads
83
PlumX Metrics